Relationship between topoisomerase II α (Topo IIα) expression and HER2 status in breast cancer.

被引：0
|
作者：
Jacobs, TW
Pliss, N
Schnitt, SJ
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
146
引用
收藏
页码：28A / 28A
页数：1
相关论文
共 50 条
  • [21] Intratumoral heterogeneity of HER2/neu and topoisomerase IIα in breast cancer:: a case with clonal monosomy 17
    Corzo, C
    Tusquets, I
    Suarez, M
    Fabregat, X
    Salido, M
    Solé, F
    Corominas, JM
    CANCER GENETICS AND CYTOGENETICS, 2004, 154 (01) : 89 - 90
  • [22] Metastatic breast cancer survival according to HER2 and Topo2a gene status
    Todorovic-Rakovic, N.
    Neskovic-Konstantinovic, Z.
    Nikolic-Vukosavljevic, D.
    DISEASE MARKERS, 2009, 26 (04) : 171 - 180
  • [23] HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression
    Seo, A. -N.
    Jeong, J. -Y.
    Lee, S. -J.
    Choe, G. -Y.
    Kwak, Y. -J.
    Kim, W. -H.
    Lee, H. -S.
    VIRCHOWS ARCHIV, 2014, 465 : S223 - S223
  • [24] HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
    Seo, An Na
    Kwak, Yoonjin
    Kim, Duck-Woo
    Kang, Sung-Bum
    Choe, Gheeyoung
    Kim, Woo Ho
    Lee, Hye Seung
    PLOS ONE, 2014, 9 (05):
  • [25] Comparison of Immunohistochemistry and Fluorescence In Situ Hybridization for the Analysis of HER2/neu and Topoisomerase II-alpha Status in Human Breast Cancer
    Pala, Emel Ebru
    Zekioglu, Osman
    Ozdemir, Necmettin
    Yilmaz, Rasih
    Kapkac, Murat
    TURKISH JOURNAL OF PATHOLOGY, 2010, 26 (03) : 222 - 229
  • [26] Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer
    Durbecq, V
    Desmedt, C
    Paesmans, M
    Cardoso, F
    Di Leo, A
    Mano, M
    Rouas, G
    Leroy, JY
    Sotiriou, C
    Piccart, M
    Larsimont, D
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (05) : 1473 - 1479
  • [27] Final results of a meta-analysis testing HER2 and topoisomerase IIα genes as predictors of incremental benefit from anthracyclines in breast cancer.
    Di Leo, A.
    Desmedt, C.
    Bartlett, J. A.
    Ejlertsen, B.
    Pritchard, K. I.
    Poole, C. J.
    Larsimont, D.
    Tanner, M.
    Plette, F.
    Buyse, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Phase I dose-escalation trial of a recombinant HER2 vaccine in patients with Stage II/II HER2+ breast cancer.
    Limentani, S
    Dorval, T
    White, S
    Curigliano, G
    Campone, M
    Disis, N
    Piccart, M
    Cheever, M
    Gérard, C
    Brichard, VG
    Gauducheau, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 170S - 170S
  • [29] Association of HER2 expression with pathologic features and prognosis in stage II and III colon cancer.
    Wu, Zehua
    Hu, Huabin
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Effect of heterogeneity of HER2 expression on brain metastases of breast cancer.
    Hosonaga, Mari
    Arima, Yoshimi
    Sugihara, Eiji
    Kohno, Norio
    Saya, Hideyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345